Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HHT9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 91 | 95 | PF00656 | 0.529 |
CLV_NRD_NRD_1 | 234 | 236 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 41 | 43 | PF00675 | 0.507 |
CLV_PCSK_KEX2_1 | 234 | 236 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.327 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.497 |
CLV_PCSK_SKI1_1 | 235 | 239 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.463 |
DEG_APCC_DBOX_1 | 128 | 136 | PF00400 | 0.536 |
DEG_APCC_DBOX_1 | 234 | 242 | PF00400 | 0.571 |
DOC_CYCLIN_RxL_1 | 38 | 46 | PF00134 | 0.470 |
DOC_MAPK_gen_1 | 129 | 137 | PF00069 | 0.542 |
DOC_MAPK_gen_1 | 234 | 240 | PF00069 | 0.551 |
DOC_PP1_RVXF_1 | 131 | 138 | PF00149 | 0.594 |
DOC_PP4_FxxP_1 | 137 | 140 | PF00568 | 0.500 |
DOC_PP4_FxxP_1 | 50 | 53 | PF00568 | 0.547 |
DOC_USP7_MATH_1 | 32 | 36 | PF00917 | 0.533 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.500 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.369 |
DOC_USP7_MATH_2 | 140 | 146 | PF00917 | 0.426 |
DOC_USP7_UBL2_3 | 22 | 26 | PF12436 | 0.638 |
LIG_14-3-3_CanoR_1 | 133 | 138 | PF00244 | 0.454 |
LIG_14-3-3_CanoR_1 | 42 | 48 | PF00244 | 0.473 |
LIG_BRCT_BRCA1_1 | 144 | 148 | PF00533 | 0.530 |
LIG_BRCT_BRCA1_1 | 164 | 168 | PF00533 | 0.492 |
LIG_deltaCOP1_diTrp_1 | 80 | 87 | PF00928 | 0.461 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.443 |
LIG_FHA_1 | 173 | 179 | PF00498 | 0.526 |
LIG_FHA_1 | 180 | 186 | PF00498 | 0.490 |
LIG_FHA_1 | 19 | 25 | PF00498 | 0.714 |
LIG_FHA_2 | 197 | 203 | PF00498 | 0.481 |
LIG_FHA_2 | 228 | 234 | PF00498 | 0.422 |
LIG_FHA_2 | 25 | 31 | PF00498 | 0.474 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.649 |
LIG_FHA_2 | 75 | 81 | PF00498 | 0.482 |
LIG_GBD_Chelix_1 | 114 | 122 | PF00786 | 0.343 |
LIG_LIR_Apic_2 | 136 | 140 | PF02991 | 0.497 |
LIG_LIR_Gen_1 | 105 | 115 | PF02991 | 0.393 |
LIG_LIR_Gen_1 | 145 | 156 | PF02991 | 0.579 |
LIG_LIR_Gen_1 | 46 | 53 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 105 | 110 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 145 | 151 | PF02991 | 0.523 |
LIG_LIR_Nem_3 | 46 | 50 | PF02991 | 0.431 |
LIG_Pex14_1 | 112 | 116 | PF04695 | 0.351 |
LIG_Pex14_1 | 170 | 174 | PF04695 | 0.507 |
LIG_Pex14_1 | 40 | 44 | PF04695 | 0.481 |
LIG_Pex14_1 | 83 | 87 | PF04695 | 0.424 |
LIG_PTB_Apo_2 | 101 | 108 | PF02174 | 0.502 |
LIG_SH2_NCK_1 | 164 | 168 | PF00017 | 0.453 |
LIG_SH2_STAP1 | 164 | 168 | PF00017 | 0.453 |
LIG_SH2_STAP1 | 174 | 178 | PF00017 | 0.513 |
LIG_SH2_STAT3 | 127 | 130 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.519 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.512 |
LIG_TRAF2_1 | 199 | 202 | PF00917 | 0.307 |
LIG_WRC_WIRS_1 | 134 | 139 | PF05994 | 0.376 |
MOD_CK2_1 | 196 | 202 | PF00069 | 0.485 |
MOD_CK2_1 | 227 | 233 | PF00069 | 0.427 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.443 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.668 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.578 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.452 |
MOD_N-GLC_1 | 142 | 147 | PF02516 | 0.518 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.494 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.415 |
MOD_NEK2_1 | 172 | 177 | PF00069 | 0.442 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.454 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.629 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.394 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.550 |
MOD_NEK2_2 | 174 | 179 | PF00069 | 0.517 |
MOD_PIKK_1 | 154 | 160 | PF00454 | 0.490 |
MOD_PIKK_1 | 214 | 220 | PF00454 | 0.290 |
MOD_PIKK_1 | 48 | 54 | PF00454 | 0.555 |
MOD_PKA_2 | 188 | 194 | PF00069 | 0.458 |
MOD_PKB_1 | 131 | 139 | PF00069 | 0.601 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.472 |
MOD_Plk_2-3 | 61 | 67 | PF00069 | 0.613 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.436 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.626 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.336 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.462 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.522 |
TRG_DiLeu_BaEn_4 | 202 | 208 | PF01217 | 0.503 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.512 |
TRG_ER_diArg_1 | 128 | 131 | PF00400 | 0.514 |
TRG_ER_diArg_1 | 192 | 195 | PF00400 | 0.562 |
TRG_ER_diArg_1 | 234 | 236 | PF00400 | 0.566 |
TRG_ER_diArg_1 | 40 | 42 | PF00400 | 0.507 |
TRG_Pf-PMV_PEXEL_1 | 198 | 202 | PF00026 | 0.309 |
TRG_Pf-PMV_PEXEL_1 | 41 | 45 | PF00026 | 0.461 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCM0 | Leptomonas seymouri | 56% | 100% |
A0A1X0P8Z9 | Trypanosomatidae | 35% | 94% |
A0A3S7X2Y0 | Leishmania donovani | 81% | 100% |
A0A422NET6 | Trypanosoma rangeli | 29% | 90% |
A4I4Y6 | Leishmania infantum | 81% | 100% |
C9ZKJ7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 81% |
E9AEE4 | Leishmania major | 81% | 100% |